NO914490L - Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser

Info

Publication number
NO914490L
NO914490L NO91914490A NO914490A NO914490L NO 914490 L NO914490 L NO 914490L NO 91914490 A NO91914490 A NO 91914490A NO 914490 A NO914490 A NO 914490A NO 914490 L NO914490 L NO 914490L
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
tricyclic compounds
analogy procedure
effective tricyclic
Prior art date
Application number
NO91914490A
Other languages
English (en)
Other versions
NO914490D0 (no
Inventor
Jacob Berger
Robin D Clark
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO914490D0 publication Critical patent/NO914490D0/no
Publication of NO914490L publication Critical patent/NO914490L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO91914490A 1990-11-16 1991-11-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser NO914490L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/614,326 US5189041A (en) 1990-11-16 1990-11-16 Tricyclic 5-ht3 receptor antagonists

Publications (2)

Publication Number Publication Date
NO914490D0 NO914490D0 (no) 1991-11-15
NO914490L true NO914490L (no) 1992-05-18

Family

ID=24460766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914490A NO914490L (no) 1990-11-16 1991-11-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser

Country Status (17)

Country Link
US (1) US5189041A (no)
EP (1) EP0485962A3 (no)
JP (1) JPH04283587A (no)
KR (1) KR920009828A (no)
AU (1) AU8785291A (no)
CA (1) CA2055680A1 (no)
FI (1) FI915400A (no)
HU (1) HUT59406A (no)
IE (1) IE913987A1 (no)
IL (1) IL100061A0 (no)
IT (1) IT1250049B (no)
MX (1) MX9102076A (no)
NO (1) NO914490L (no)
PL (1) PL292419A1 (no)
PT (1) PT99518A (no)
TW (1) TW208007B (no)
ZA (1) ZA919078B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96486A (en) * 1989-11-28 1995-03-30 Syntex Inc Preparation tricyclic compounds and pharmaceutical preparations containing them
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
EP0884319B1 (en) * 1992-03-12 2004-05-06 SmithKline Beecham plc N- (1-nButyl-4-piperidyl)methyl -3,4-dihydro-2H- 1,3 oxazino 3,2-a indole-10-carboxamide or a pharmaceutically acceptable salt thereof
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
EP0623582B1 (de) * 1993-04-27 1998-01-07 Solvay Fluor und Derivate GmbH Verfahren zur Herstellung von Carbonsäureestern aus Carbonsäurehalogeniden und Alkoholen
US6489355B2 (en) * 1993-12-01 2002-12-03 Eli Lilly And Company Methods of inhibiting the effects of amyloidogenic proteins
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
IT1303123B1 (it) 1998-10-13 2000-10-30 Rotta Research Lab Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
WO2001087305A2 (en) * 2000-05-18 2001-11-22 Glaxo Group Limited Method for treating functional dyspepsia using alosetron
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
BR0214016A (pt) 2001-11-09 2004-10-13 Upjohn Co Compostos azabicìclico-fenil-fundido heterocìclicos e seu uso como ligandos alfa 7 nachr
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
DK2540297T3 (en) 2008-11-19 2015-07-13 Forum Pharmaceuticals Inc The treatment of cognitive disorders with (R) -7-chloro-N- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
US9145396B2 (en) * 2008-12-01 2015-09-29 Targacept, Inc. Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
BR112012029237A2 (pt) 2010-05-17 2016-11-29 Envivo Pharmaceuticals Inc forma cristalina de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida monohidratado
RU2635522C2 (ru) 2012-05-08 2017-11-13 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2121394A1 (fr) * 1971-01-08 1972-08-25 Anvar Procédé d'obtention de dérivés d'acides indole carboxyliques et produits préparables par ce procédé.
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
FR2475394A1 (fr) * 1980-02-12 1981-08-14 Synthelabo Compositions pharmaceutiques contenant l'hexahydro-1, 2, 3, 3a, 4, 5, 6h indolo (3, 2, 1 - d. e) (1, 5) naphtyridinone - 6
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
JP2765845B2 (ja) * 1986-11-21 1998-06-18 グラクソ、グループ、リミテッド 中止症候群の予防の治療薬
DE3851597T2 (de) * 1987-09-03 1995-01-26 Glaxo Group Ltd., London Lactamderivate.
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5008272A (en) * 1988-08-15 1991-04-16 Glaxo Group Limited Lactam derivatives
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
CA2012092A1 (en) * 1989-03-13 1990-09-13 Tadao Okegawa 5-ht3 receptor antagonist
JPH02290878A (ja) * 1989-04-28 1990-11-30 Ono Pharmaceut Co Ltd ベンゾチエノ（フロ）ピリジン誘導体

Also Published As

Publication number Publication date
CA2055680A1 (en) 1992-05-17
US5189041A (en) 1993-02-23
HU913579D0 (en) 1992-01-28
HUT59406A (en) 1992-05-28
KR920009828A (ko) 1992-06-25
ZA919078B (en) 1993-05-17
PT99518A (pt) 1992-09-30
MX9102076A (es) 1992-07-08
EP0485962A3 (en) 1992-07-29
PL292419A1 (en) 1993-04-05
NO914490D0 (no) 1991-11-15
IE913987A1 (en) 1992-05-20
ITTO910865A1 (it) 1992-05-17
EP0485962A2 (en) 1992-05-20
ITTO910865A0 (it) 1991-11-12
TW208007B (no) 1993-06-21
IT1250049B (it) 1995-03-30
FI915400A (fi) 1992-05-17
IL100061A0 (en) 1992-08-18
FI915400A0 (fi) 1991-11-15
AU8785291A (en) 1992-05-21
JPH04283587A (ja) 1992-10-08

Similar Documents

Publication Publication Date Title
NO914825L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider
NO914490L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO921777L (no) Fremgangsmaate for fremstilling av isoparaffiner
NO172570C (no) Fremgangsmaate ved fremstilling av granulater
NO171913C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser
NO910395L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO933904D0 (no) Fremgangsmaate for fremstilling av aromatiske brommetylforbindelser
NO912797D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO914053L (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO913692L (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO180675C (no) Fremgangsmåte for fremstilling av aromatiske forbindelser
NO173871C (no) Fremgangsmaate for fremstilling av penemforbindelser
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO914985L (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO932783D0 (no) Fremgangsmaate for fremstilling av imidazopyridiner
NO903397D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO920849D0 (no) Fremgangsmaate for fremstilling av l-lysin ved fermentasjon
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin